Pituitary

Scope & Guideline

Innovating Endocrine Research for Tomorrow's Solutions

Introduction

Explore the comprehensive scope of Pituitary through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Pituitary in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1386-341x
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1998 to 2024
AbbreviationPITUITARY / Pituitary
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The journal 'Pituitary' focuses on advancing the understanding of pituitary diseases and disorders through high-quality research. Its aims encompass a wide range of topics related to pituitary function, pathologies, and treatment modalities, utilizing various methodologies including clinical studies, systematic reviews, and meta-analyses.
  1. Clinical Management of Pituitary Disorders:
    The journal emphasizes research on the clinical management of various pituitary disorders including acromegaly, Cushing's syndrome, and prolactinomas, exploring treatment efficacy and safety.
  2. Endocrine and Metabolic Research:
    A significant focus is placed on the endocrine implications of pituitary dysfunction, including hormonal therapies and their metabolic effects, with studies often examining the interaction between hormonal levels and systemic health.
  3. Surgical Techniques and Outcomes:
    Research on innovative surgical techniques, particularly endoscopic approaches for pituitary tumors, and their outcomes is a core area, aiming to improve patient safety and surgical success rates.
  4. Pathophysiology and Molecular Mechanisms:
    The journal includes studies that investigate the underlying pathophysiological mechanisms of pituitary tumors and related disorders, contributing to a better understanding of these complex conditions.
  5. Patient-Centered Outcomes and Quality of Life:
    There is a consistent focus on patient-reported outcomes and quality of life assessments, highlighting the psychosocial impact of pituitary disorders and treatments.
The journal has identified several trending and emerging themes in pituitary research, reflecting the evolving landscape of clinical practice and scientific inquiry in this field. These themes highlight areas of increasing focus and potential importance for future research.
  1. Impact of COVID-19 on Pituitary Disorders:
    Recent publications have increasingly addressed the implications of COVID-19 on patients with pituitary disorders, exploring both the direct and indirect effects of the pandemic on management and outcomes.
  2. Integration of Artificial Intelligence in Clinical Practice:
    There is a growing interest in the application of artificial intelligence and machine learning models in predicting outcomes and aiding in the clinical decision-making process for pituitary disorders.
  3. Long-term Outcomes of Hormonal Therapies:
    Emerging research is focusing on the long-term effects and outcomes of hormonal therapies, particularly in relation to acromegaly and Cushing's syndrome, reflecting a trend towards understanding the chronic implications of these treatments.
  4. Patient-Centered Research and Quality of Life:
    A notable increase in studies assessing patient-reported outcomes and quality of life following treatment for pituitary disorders indicates a shift towards more holistic approaches in managing these conditions.
  5. Research on Comorbidities Associated with Pituitary Disorders:
    There is an increasing trend in exploring the comorbid conditions associated with pituitary disorders, particularly metabolic and cardiovascular risks, emphasizing the need for comprehensive management strategies.

Declining or Waning

While the journal has a robust focus on various aspects of pituitary research, some themes appear to be declining in prominence. These waning scopes indicate shifts in research priorities or reduced interest in certain areas over recent years.
  1. Historical Perspectives on Pituitary Disorders:
    Research that focuses on historical or retrospective analyses of pituitary disorders or treatments has seen a decline, as the field shifts towards more contemporary studies with immediate clinical relevance.
  2. Basic Science and Animal Models:
    There is a noticeable decrease in studies involving basic science and animal models of pituitary disorders, as clinical applications and human studies gain more traction.
  3. Epidemiological Studies on Rare Pituitary Tumors:
    The frequency of epidemiological studies specifically targeting rare pituitary tumors has diminished, possibly due to the challenges in gathering sufficient data on these less common conditions.
  4. General Reviews on Common Pituitary Disorders:
    While systematic reviews remain important, there is less emphasis on general reviews of well-established pituitary disorders, as the focus shifts to more specific and novel research findings.

Similar Journals

Archives of Endocrinology Metabolism

Championing open access to vital endocrinology insights.
Publisher: SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAISSN: 2359-3997Frequency: 6 issues/year

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

JOURNAL OF ENDOCRINOLOGY

Unraveling the Complexities of Endocrinology
Publisher: BIOSCIENTIFICA LTDISSN: 0022-0795Frequency: 12 issues/year

JOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.

JOURNAL OF MOLECULAR ENDOCRINOLOGY

Innovating Research at the Intersection of Hormones and Biology
Publisher: BIOSCIENTIFICA LTDISSN: 0952-5041Frequency: 6 issues/year

JOURNAL OF MOLECULAR ENDOCRINOLOGY, published by BIOSCIENTIFICA LTD, is a prestigious academic journal that has made significant contributions to the fields of endocrinology and molecular biology since its inception in 1988. With an impressive impact factor that places it in the Q1 category for Endocrinology and Q2 for Molecular Biology, this journal is recognized for its rigorous peer-reviewed research that addresses key questions at the intersection of molecular mechanisms and hormonal regulation. The journal's accessibility within the Scopus rankings, notably positioned 45th out of 128 in Endocrinology, highlights its relevance and influence in shaping contemporary scientific discourse. Although the journal does not currently offer open access options, it remains an essential resource for researchers, professionals, and students eager to explore groundbreaking discoveries and advancements in the hormonal sciences. The JOURNAL OF MOLECULAR ENDOCRINOLOGY continues to pave the way for critical exploration and innovation, ensuring its place as a vital publication for the advancement of knowledge in molecular endocrinology.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Advancing knowledge in endocrine health.
Publisher: SPRINGERISSN: 1389-9155Frequency: 6 issues/year

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

International Journal of Endocrinology

Fostering collaboration to tackle endocrine challenges worldwide.
Publisher: HINDAWI LTDISSN: 1687-8337Frequency:

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Elevating research in physiology and metabolic science.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1849Frequency: 12 issues/year

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

BMC Endocrine Disorders

Elevating discussions in diabetes and metabolism.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.

MOLECULAR AND CELLULAR ENDOCRINOLOGY

Elevating research standards in the molecular and cellular sciences.
Publisher: ELSEVIER IRELAND LTDISSN: 0303-7207Frequency: 21 issues/year

MOLECULAR AND CELLULAR ENDOCRINOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal resource in the fields of biochemistry, endocrinology, and molecular biology. With an ISSN of 0303-7207 and E-ISSN of 1872-8057, this esteemed journal has been disseminating significant findings since its inception in 1974 and continues to do so through 2024. Ranked in the Q1 quartile for Biochemistry and Q2 for both Endocrinology and Molecular Biology, it is recognized for its impactful contributions to research, holding impressive Scopus rankings that place it at the forefront of its category. The journal's wide-reaching influence is underscored by its commitment to quality, ensuring that only the most impactful articles advance the understanding of cellular mechanisms and hormonal regulation. Although not open-access, its relevance and rigorous peer-review process make it an essential read for researchers, professionals, and students eager to explore the complexities of endocrinology and biochemistry.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Empowering Knowledge for Young Lives
Publisher: WALTER DE GRUYTER GMBHISSN: 0334-018XFrequency: 12 issues/year

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

Hormones-International Journal of Endocrinology and Metabolism

Exploring the Nexus of Endocrinology and Metabolism
Publisher: SPRINGER INT PUBL AGISSN: 1109-3099Frequency: 4 issues/year

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.